A trial looking at docetaxel and RAD001 for head and neck cancer that has spread or has come back after treatment (DORA)

Overview

Cancer types:

Head and neck cancers, Laryngeal cancer, Mouth and oropharyngeal cancer, Nasal and paranasal sinus cancer , Nasopharyngeal cancer, Pharyngeal cancer

Status:

Results

Phase:

Phase 1/2

Details

This trial was trying to find out if having a drug called RAD001 (also called everolimus and Afinitor) at the same time as chemotherapy helped people with head and neck cancer that had spread or had come back after treatment.

The trial was for people who had head and neck cancer that had started in the flat, skin like cells lining the cavities of the head and neck. These cells are called squamous cells. You may hear your doctor call this type of cancer .

This trial was supported by Cancer Research UK.

Recruitment start: 3 June 2009

Recruitment end: 12 April 2011